Sullivan, Bruyette, Speros & Blaney’s Seagen Inc. Common Stock SGEN Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,189	Closed	-$187K	–	351
2019 Q3	$187K	Sell	2,189 -4,500	-67%	-$330K	0.01%	248
2019 Q2	$463K	Hold	6,689	–	–	0.03%	135
2019 Q1	$490K	Hold	6,689	–	–	0.03%	122
2018 Q4	$379K	Hold	6,689	–	–	0.03%	133
2018 Q3	$516K	Hold	6,689	–	–	0.05%	95
2018 Q2	$444K	Sell	6,689 -45	-0.7%	-$2.58K	0.04%	97
2018 Q1	$352K	Buy	6,734 +21	+0.3%	+$1.14K	0.03%	119
2017 Q4	$359K	Hold	6,713	–	–	0.03%	119
2017 Q3	$365K	Buy	6,713 +24	+0.4%	+$1.23K	0.04%	113
2017 Q2	$346K	Hold	6,689	–	–	0.03%	112
2017 Q1	$420K	Hold	6,689	–	–	0.04%	90
2016 Q4	$353K	Sell	6,689 -1,000	-13%	-$60.1K	0.04%	98
2016 Q3	$415K	Buy	+7,689	New	+$365K	0.04%	87

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's SGEN Position: Q4 2019 in Review

Sullivan, Bruyette, Speros & Blaney sold out of Seagen Inc. Common Stock (SGEN) in Q4 2019, closing a stake of 2,189 shares — an estimated $187K sold.

Sullivan, Bruyette, Speros & Blaney first reported a position in SGEN in Q3 2016 and held it in 13 quarters. The position peaked at $516K in Q3 2018. 396 funds tracked by Wall St. Rank hold SGEN as of Q4 2019.

Sullivan, Bruyette, Speros & Blaney reported no remaining Seagen Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Sullivan, Bruyette, Speros & Blaney sold 2,189 Seagen Inc. Common Stock shares in Q4 2019, an estimated $187K.
Sullivan, Bruyette, Speros & Blaney first reported a position in Seagen Inc. Common Stock in Q3 2016 and held it in 13 quarters.
Sullivan, Bruyette, Speros & Blaney's Seagen Inc. Common Stock position peaked at $516K in Q3 2018.
396 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2019.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q4 2019, filed 13 Feb 2020.